Singularity Hub

Still experimental. Facial expressions and body posture — critical parts of sign language — are outside its scope for now. But the usability barrier that has limited this field for decades just got meaningfully smaller.

Trained on 100 ASL and ISL signs. 88% accuracy for first-time users. AI autocomplete keeps pace with natural signing speed — 100 to 150 signs per minute.

70 million people use sign language. Most of the world can't follow along. Seven wireless AI rings just moved that gap meaningfully closer to closed. 🧵singularityhub.com/2026/05/12/the…

The practical implication: robot skills become reusable assets. A single demonstration scales across a mixed fleet. Upgrading hardware doesn't mean restarting training. Progress on deployment friction doesn't generate headlines. It's what actually determines how quickly robotics reaches scale in industry.

The system's honest limitation: it's best suited to controlled factory environments, not unpredictable real-world settings. Complex decisions and messy environments are still out of scope. But controlled factory environments are exactly where the vast majority of industrial robot deployment happens today.

Every time a factory upgrades to a new robot model, all the trained skills break. The new robot starts from scratch. At scale, that retraining cost is a serious bottleneck. Researchers just published a fix — and it doesn't require AI. 🧵 singularityhub.com/2026/05/01/rob…

What this study establishes is a specific and meaningful benchmark: real-world diagnostic reasoning, in actual ER cases with all their messiness, at or above physician level. The question for healthcare leaders has shifted. Not: can AI reason clinically? But: how do you deploy something this capable safely, equitably, and accountably across the full complexity of real healthcare systems?

The honest picture: o1-preview is not ready for clinical deployment. Medical AI has documented racial bias with measurable impact on patient outcomes. ChatGPT Health launched this year and has already drawn criticism for missing emergencies in early use. The researchers are explicit: rigorous clinical trials are needed before real-world use. Accuracy is necessary. It is not sufficient.

AI has been acing medical licensing exams for years. That's a controlled environment. Clean data. No noise. Researchers just tested a different question: how does AI perform on real ER cases, with real patient records, in real clinical conditions?🧵 singularityhub.com/2026/05/04/an-…

Nearly every disease associated with aging has a mitochondrial component. When a precision delivery tool exists for cell therapy, the range of conditions it can potentially address expands dramatically.

The system isn't ready for clinical use — it requires extensive genetic engineering, and how long transplanted mitochondria persist in their new hosts remains unclear. But the foundational delivery problem has been cleared in principle.

Mitochondria power every cell in your body. When they fail — Alzheimer's, heart failure, diabetes, & inherited blindness follow. Scientists just cleared the biggest obstacle to transplanting healthy ones directly into failing cells. 🧵 singularityhub.com/2026/04/21/sci…